TARGET ASTRAZENECA

**********************************************************************
This list contains more than 600 possibilities to contact AstraZeneca. All emails compiled find at the end. To look for researchers who use animals for their evil job, search "experiment" or consult the paragraphs France, Sweden, UK and USA.
**********************************************************************


AstraZeneca operates through 254 subsidiaries worldwide.

"In 2010, we used approximately 408,000 animals
in-house (2009: 393,000). In addition, approximately 21,000 animals
were used by external CROs on our behalf (2009: 17,000)."
Source: Annual Report 2010, p. 44


INTERNATIONAL

AstraZeneca (Global HQ)
Floors 7-9,
Two Kingdom Street, Paddington Central
London, W2 6BD
United Kingdom

Tel: +44 (0)20 7604 8000
Tel: +44 (0)20 7304 5000
Fax: +44 (0)20 7304 5151
 info@astrazeneca.com
 info@astrazeneca.co.uk
 ir@astrazeneca.com
 http://www.astrazeneca.com

AstraZeneca AB
SE-151 85
Södertälje
Sweden

Tel: +46 (0)8 553 260 00
Fax: +46 (0)8 553 290 00


Research Sites International

The sites include the main small molecule facilities in the UK (Alderley Park and Macclesfield); Sweden (Mölndal) and the US (Waltham, Massachusetts). Other sites that have a focus on research are in Sweden (Södertälje), Canada (Montreal, Quebec) and France (Reims). They have a
clinical development facility in Osaka, Japan. The principal sites
for biologics and vaccines are in the US (Gaithersburg, Maryland
and Mountain View, California) and the UK (Cambridge).


Investor Relations
AstraZeneca Pharmaceuticals LP
1800 Concord Pike
PO Box 15437, Wilmington
DE 19850-5437, USA

Tel: +1 (302) 886 3000
Fax: +1 (302) 886 2972

David R. Brennan
Chief Executive Officer
 david.brennan@astrazeneca.com

Simon Lowth
Executive Director, CFO

Directors

Louis Schweitzer
Non-Executive Chairman, Chairman of the Nomination and
Governance Committee and member of the Remuneration Committee
 louis.schweitzer@astrazeneca.com

Bruce Burlington
Non-Executive Director and member of the Science Committee
 bruce.burlington@astrazeneca.com

Shriti Vadera
Non-Executive Director and member of the Science Committee , Non-Executive Director and member of the Audit Committee
Director
 shriti.vadera@astrazeneca.com

Jean-Philippe Courtois Chancellor of the Exchequer, Council of Economic Advisers,
Non-Executive Director and member of the Audit Committee
 jean-philippe.courtois@astrazeneca.com

John Varley
Non-Executive Director, Chairman of the Remuneration Committee
and member of the Nomination and Governance Committee
 john.varley@astrazeneca.com

Michele Hooper
Non-Executive Director
 michele.hooper@astrazeneca.com

Marcus Wallenberg
Non-Executive Director and member of the Science Committee

Rudy Markham
Non-Executive Director and member of the Audit Committee and the
Remuneration Committee
 rudy.markham@astrazeneca.com

Nancy Rothwell
Non-Executive Director, Chairman of the Science Committee and member
 nancy.rothwell@astrazeneca.com

other AstraZeneca Senior Management
Chief Financial Officer:  jon.symonds@astrazeneca.com
Executive Vice-President North America:  tony.zook@astrazeneca.com
Executive Vice-President, Europe and ROW:  bruno.angelici@astrazeneca.com
Executive Vice-President, Operations:  barrie.thorpe@astrazeneca.com
Executive Vice-President Discovery Research:  jan.lundberg@astrazeneca.com
Executive Vice-President Human Resources:  tony.bloxham@astrazeneca.com
Senior Non-Executive Director:  peter.bonfield@astrazeneca.com


other EXECUTIVES

Lynn Tetrault
Executive Vice-President, Human Resources and Corporate Affairs
 lynn.tetrault@astrazeneca.com

Jeff Pott
General Counsil
 jeff.pott@astrazeneca.com

Science Committee

The Science Committee's core role continues to be to provide
assurance to the Board regarding the quality, competitiveness and
integrity of the Group's R&D activities by way of: meetings and dialogue with our R&D leaders and other scientist employees; visits to R&D sites throughout the world; and review and assessment ...
During 2010, the members of the Science Committee, all of whom
have a knowledge of, or an interest in, life sciences, were Nancy
Rothwell (Chairman of the Committee), Jane Henney, Bruce
Burlington (from his appointment as a Non-Executive Director in
August), Marcus Wallenberg (from 28 April 2010) and Bo Angelin
(until his retirement from the Board on 29 April 2010), all Non-
Executive Directors. The President, Global R&D; the Executive
Vice-President, Innovative Medicines; the Senior Vice-President,
R&D, MedImmune; and the Executive Vice-President.

Martin Mackay
President, Global R&D
 martin.mackay@astrazeneca.com

Nancy Rothwell
 nancy.rothwell@astrazeneca.com

Jane Henney
 jane.henney@astrazeneca.com

Bruce Burlington
 bruce.burlington@astrazeneca.com

Marcus Wallenberg
 marcus.wallenberg@astrazeneca.com

others

John Buchanan
 john.buchanan@astrazeneca.com

Simon Appleby
Vice-President, Performance and Reward
 simon.appleby@astrazeneca.com

Viv Gill
 viv.gill@astrazeneca.com

Katie Jackson-Turner
 katie.jackson-turner@astrazeneca.com

****************************************************************

MAJOR SHAREHOLDES OF ASTRAZENECA

BlackRock, Inc.
Invesco Limited
Axa SA
Investor AB
Legal & General Investment Management Limited
Capital Research and Management Company
Wellington Management Co., LLP
Barclays PLC

US Depositary
JPMorgan Chase & Co
PO Box 64504
St Paul
MN 55164-0504

Tel (toll free in the US): 800 990 1135
Tel (outside the US): +1 (651) 453 2128
 jpmorgan.adr@wellsfargo.com

*****************************************************************

COUNTRIES


AUSTRALIA

Astra Tech Pty Ltd
Suite 1, 53 Grandview Street, NSW 2073, Pymble
ph: +61 2 9488 3500
Fax +61 2 9440 0744
 info.au@astratech.com
 http://www.astrazeneca.com.au

Cecelia Bagley
Phone: +61 7 3340 1000
 cecelia.bagley@astratech.com

Joanne Davis
 joanne.davis@astrazeneca.com


AUSTRIA

AstraZeneca Österreich GmbH
Schwarzenbergplatz 7
1030 Wien
Tel. +43 1 711 31 438
Fax +43 1 711 31 221
 info.at@astrazeneca.com
 webmaster.at@astrazeneca.com
 bewerbungen.at@astrazeneca.com

Astra Tech GesmbH
Schlosshofer Strasse 4/4/19
1210 Wien
Tel: +43 (1) 214 61 500
Fax: +43 (1) 214 61 67
 info.at@astratech.com
 order.dental.at@astratech.com
 http://www.astratechdental.at
 http://www.astratech.co.at


Luc Angele Marie Raymond Vranken
CEO
 luc.vranken@astrazeneca.com

Dr. Helmut Pauliny
former CEO
 helmut.pauliny@astrazeneca.com

Mag. Dr Irene Helk-Schläger
 irene.helk-schlaeger@astrazeneca.com

Mag. Martin Fuchs
 martin.fuchs@astrazeneca.com

Mag. Martin Munte
 martin.munte@astrazeneca.com

Rudi Dobber
 rudi.dobber@astrazeneca.com

Mag. Peter Prokop
 peter.prokop@astrazeneca.com

Dr. Johannes Farkas
 johannes.farkas@astrazeneca.com

Mag.(FH) Elmar Fleck
 elmar.fleck@astrazeneca.com

Benoit J.D. Quittre
 benoit.quittre@astrazeneca.com

Frank Mitterer
 frank.mitterer@astrazeneca.com

Dr. Christian Dreger
 christian.dreger@astrazeneca.com


BELGIUM

Egide Van Ophemstraat 110
1180 Brussel

Tel: +32 (0)2 370 48 11
Fax: +32 (0)2 332 29 69
 info.be@astrazeneca.com
 HR.be@astrazeneca.com
 dataprivacy.belgium@astrazeneca.com
 patientsafety.belgium@astrazeneca.com

 http://www.astrazeneca.be

NV AstraZeneca SA
Egide Van Ophemstraat 110
1180 Ukkel

Foundation AstraZeneca
Sofie Feyaerts
Egide Van Ophemstraat 110
1180 Ukkel
Tel 02 370 48 33
 Secretariat.FoundationBelgium@astrazeneca.com
 sofie.feyaerts@astrazeneca.com

Apr. PP Schutyser
CEO

Dhr. Joris Silon
General Manager
 joris.silon@astrazeneca.com


BULGARIA

 reception.sofia@astrazeneca.com

Zoya Paunova
Country Manager
 zoya.paunova@astrazeneca.com

Milena Evrova
Tel +359 2 971 38 03
 milena.evrova@astrazeneca.com

Stoyanka Muhovska
Tel +359 2 971 25 34
 stoyanka.muhovska@astrazeneca.com


BRAZIL

 RHSelecao@astrazeneca.com


CANADA

AstraZeneca Canada Inc.
1004 Middlegate Rd
MISSISSAUGA, Ontario
L4Y 1M4

Tel: +1 (905) 277-7111
Toll Free Phone: (800) 565-5877
Fax: +1 (905) 270-3248
 medinfo.canada@astrazeneca.com
 customer.relations1@astrazeneca.com
 RecruitmentCA@astrazeneca.com
 http://www.astrazeneca.ca

AstraZeneca R&D Montreal
7171 Frederick-Banting, Ville St. Laurent
Montreal, Quebec H4S 1Z9
ph: +1 514 832 3200
Fax +1 514 8323232
 http://www.astrazeneca-montreal.com

Michael Cloutier
President, Management Executive
Tel. (905) 277-7111
 michael.cloutier@astrazeneca.com

William Charnetsky
Vice President, Corporate Affairs
Telephone: (905) 277-7111
 william.charnetsky@astrazeneca.com

Michelle Fleming
Corporate Communications Specialist
Telephone: (905) 615-6828
Fax: (905) 275-7657
 michelle.fleming@astrazeneca.com

Carlo Mastrangelo
Director, Communications
Tel (905) 615-6865
Fax 905 2757657
 carlo.mastrangelo@astrazeneca.com

Philippe Walker, Ph.D.
Board member, one of the principal founders of the AstraZeneca Research Centre in Montreal
Tel.: (514) 832-3205
Fax: (514) 832-3228
 philippe.walker1@astrazeneca.com

Wayne Quigley
 wayne.quigley@astrazeneca.com

Kirsten Evraire
Cell: (610) 223-3771
 kirsten.evraire@astrazeneca.com

Katie Lubenow
 katie.lubenow@astrazeneca.com

Daniela Cohen
Tel +1 905 615 6827
+1-800-565-5877 ext 6827
 daniela.cohen@astrazeneca.com

Jennifer McCormack
Tel +1 905-615-6837
+1-800-565-5877 ext 6837
 jennifer.mccormack@astrazeneca.com

Alison Pozzobon
+1 905 804 5817
+1-800-565-5877 ext 5817
 alison.pozzobon@astrazeneca.com

Lee Rammage
+1 905 804 4913
+1-800-565-5877 ext 4913
 lee.rammage@astrazeneca.com

Stephanie Batcules
Communications Manager, Oncology
+1 905 615 6849
+1-800-565-5877 ext 6849
 stephanie.batcules@astrazeneca.com

Michelle Riccio
+1 905-615-6828
+1-800-565-5877 ext 6828
 michelle.riccio@astrazeneca.com

Dona Corsen
Tel +1 905-566-7323 - 6094
 dona.corsen@astrazeneca.com

Odete Correia
Tel 905-277-7111
Fax 905-277-5760
 odete.correia@astrazeneca.com


CHINA

Headquarter Office
43/F CITIC Square 1168 Nanjing West Road, Shanghai, 200041
Tel: +86 21 5256 4555
Fax: +86 21 5292 9970
 recruitment.china@astrazeneca.com
 
Innovation Center China
Building 7, 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area 201203
Tel: +86 21 6109 7800
Fax: +86 21 6109 7700
 
Manufacturing Site
No. 2 Huang Shan Road, Wuxi, Jiang Su Province, 214028
Tel: +86 510 8522 0000
Fax: +86 510 8522 7777


CZECH REPUBLIC


AstraZeneca Czech Republic, s. r. o.
Plze?sk? 3217/16
150 00 Praha 5

Tel.: +420 222 807 111
Fax: +420 222 807 221
 recepce@astrazeneca.com
 infoservis.cz@astrazeneca.com
 czdrugsafety@astrazeneca.com

MUDr. Robert Weigl
Marketing Company President
 robert.weigl@astrazeneca.com

MUDr. Jan Baer
Regional Clinical Research Director CEEMEA
 jan.baer@astrazeneca.com

Ales Kminek
 ales.kminek@astrazeneca.com

Miroslava Petrousova
 miroslava.petrousova@astrazeneca.com

Petr Divis
 petr.divis@astrazeneca.com

Vaclav Kourim
 vaclav.kourim@astrazeneca.com

Lenka Mala
 lenka.mala@astrazeneca.com


DENMARK

AstraZeneca A/S
Roskildevej 22
2620 Albertslund
Tlf: +45 43 66 64 62
Fax: +45 43 66 61 00
 http://www.astrazeneca.dk

Astra Tech A/S
Husby Allé 19
2630 Taastrup
Tel: +45 43 71 33 77
Fax: +45 43 71 78 65
 info.dk@astratech.com
 http://www.astratech.com


Nadia Vega Vasiljev
External Relations Manager
Mobil: +45 43 66 62 42
 nadiavega.vasiljev@astrazeneca.com


EGYPT

14c Ahmed Kamel St.
New Maadi, Cairo
Tel: 02 5170660, 02 5170661

Amina Varga
 amina.varga@astrazeneca.com

Maged Gobran
 maged.gobran@astrazeneca.com


ESTONIA

 estonia@astrazeneca.com


FINLAND

AstraZeneca Oy
Luomanportti 3
02200 Espoo

Tel +358 (0)10 23 010
Fax +358 (0)10 2301 500
 etunimi.sukunimi@astrazeneca.com
 rekrytointi@astrazeneca.com

Astra Tech Oy
Piispansilta 9 / Biskopsbron 9
02230 Espoo
Tel: +358 (0)9 867 61 60
Fax: +358 (0)9 804 41 28
 info.fi@astratech.com
 http://www.astratech.com

Maarit Hamalainen
Finance Manager
 maarit.hamalainen@astrazeneca.com

Raija Vakkila
 raija.vakkila@astrazeneca.com


FRANCE

ASP S.A.
224, Avenue de la Dordogne BP 41, Dunkerque Cedex 2, F-59944
ph: +33 (0)3 28 58 48 00
fax: +33 (0)3 28 60 77 82
 http://www.astrazeneca.fr

AstraZeneca France
1 Place Renault, Rueil Malmaison Cedex, F-92844
ph: +33 (0)1 41 29 40 00
fax: +33 (0)1 41 29 40 01
 http://www.astrazeneca.fr
 recrutement.france@astrazeneca.com

AstraZeneca Monts
18 Rue de Montbazon, Monts, F-37260
ph: +33 (0)2 47 21 10 10
fax: +33 (0)2 47 26 68 82
 http://www.astrazeneca.fr

AstraZeneca Reims
Parc Industriel Pompelle Chemin de Vrilly BP 1050
Reims Cedex 2, F-51689
ph: +33 (0)3 26 61 68 68
fax: +33 (0)3 26 85 58 64
 http://www.astrazeneca.fr

AstraZeneca Research Centre Reims
Parc Industriel Pompelle Chemin de Vrilly, Box 1050
Reims Cedex 2, F-51689
ph: +33 (0)3 26 61 68 68
fax: +33 (0)3 26 61 68 42

Astra Tech France
7, rue Eugène et Armand Peugeot
TSA 90002, 92563 Rueil-Malmaison Cedex
France
Tel: +33 1 41 39 02 40
Fax: +33 1 41 39 02 44
 info.fr@astratech.com
 http://www.astratech.fr


Bernard Barlaam
works in Reims, experiments: (Charles River) mice were housed in negative-pressure isolators (PFI Systems Ltd.) at Alderley Park, United Kingdom. Experiments were conducted on 8- to 12-wk-old female mice
 bernard.barlaam@astrazeneca.com


GERMANY

AstraZeneca GmbH
Tinsdaler Weg 183
22880 Wedel
Tel: +49 (04103) 708 - 0
 info@astrazeneca.de
 HR-OPS.Germany@astrazeneca.com
 http://www.astrazeneca.de

AstraZeneca GmbH
Werk Plankstadt, Otto-Hahn-Strasse
68723 Plankstadt
ph: +49 62 02 99 00
fax: +49 62 02 99 20 00
 http://www.astrazeneca.de

Astra Tech GmbH
An der kleinen Seite 8
65600 Elz
ph: +49 6431 9869 0
fax: +49 6431 9869 500
 info.de@astratech.com
 http://www.astratech.com

Gabriel Baertschi
CEO
 gabriel.baertschi@astrazeneca.com

Henning Wrogemann
former CEO, Area Vice President Southeastasia
 henning.wrogemann@astrazeneca.com

Dr. Claus Runge
Vice President Corporate Affairs
 claus.runge@astrazeneca.com

Stefan Busch
Vice President Strategic Planning/ Portfoliomanagement
 stefan.busch@astrazeneca.com

Bernd Friedrich
Vice President Commercial Excellence
 bernd.friedrich@astrazeneca.com

Thomas Gartz
Vice President Human Resources
 thomas.gartz@astrazeneca.com

Dr. Kai Richter
Vice President Medical
 kai.richter@astrazeneca.com

Carsten Nowotsch
Vice President Primary Care
 carsten.nowotsch@astrazeneca.com

Doris Mayer
CFO
 doris.mayer@astrazeneca.com

Dirk Greshake
Vice President Specialty Care
 dirk.greshake@astrazeneca.com

Kerstin Heinemann
Press officer
Tinsdaler Weg 183
22880 Wedel

Tel.: +49 04103 708 3955
Fax: 04103 /708 - 73955
 presse@astrazeneca.com
 kerstin.heinemann@astrazeneca.com

Dr. Friedrich von Heyl
Communications director
Tel.: +49-4103-708-3878
 friedrich.vonheyl@astrazeneca.com


GREECE

Theotokopoulou 4 & Astronafton 151 25
Maroussi


ICELAND

AstraZeneca Iceland
c/o Vistor hf, P.O Box 231, GardabÊr, IS-210
ph: +354 535 7151
fax: +354 565 7366
 http://www.iceland.is

INDIA

AstraZeneca India Pvt. Ltd
Bellary Road
Hebbal
Bangalore, KK - 560024
Tel: +91-80-23621 212
Fax: +91-80-23621 214
 astrazeneca.india@astrazeneca.com

Dr. Tanjore Balganesh
Tel: + 91 80 23622001
Tel 2: + 91 80 23621 212
Fax: + 91 80 23622002
 tanjore.balganesh@astrazeneca.com

Probir Guha
Phone +91-33-22837940
Fax 22890262
 probir.guha@astrazeneca.com


IRELAND

AstraZeneca Pharmaceuticals (Ireland) Ltd.
College Park House, 20 Nassau Street
Dublin 2
ph: +353 1 609 7100
fax: +353 1 679 6650


ITALY

AstraZeneca S.p.A.
Palazzo Volta Via Francesco Sforza, Basiglio (MI), 20080
ph: +39 02 98011
fax: +39 02 907 556 15
 http://www.astrazeneca.it

AstraZeneca S.p.A.
Viale dell'Industria, 3, Caponago (MI), 20040
ph: +39 02 95 45 21
fax: +39 02 954 523 00
 http://www.astrazeneca.it

Astra Tech S.p.A.
Via Cristoni, 86
400 33 Casalecchio Di Reno (BO)
ph: +39 051 298 7511
fax: +39 051 298 7580
 info.it@astratech.com
 http://www.astratech.com

HRLearning.Development& Staffing@astrazeneca.com


JAPAN

AstraZeneca K.K.
Tokyo Regional Office, Koraku Mori Bldg. 11F
1-4-14 Koraku, Bunkyo-ku
TOKYO 112-0004
Japan
Tel: +81 (0)3-5840 1113
Fax: +81 (0)3-5840 1160
 info.jp@astratech.com


MALAYSIA

AstraZeneca Sdn Bhd (69730X)
Wisma Prima, No. 17 Jalan Sri Semantan Satu
Damansara Heights, 50490 Kuala Lumpur
Fax: (03) 2089 2397
 peisan.lam@astrazeneca.com


MEXICO

 reclutamiento-mexico@astrazeneca.com


NETHERLANDS

AstraZeneca Netherlands
Tel: +31 (0)79 363 22 22
Fax: +31 (0)79 363 24 44
 http://www.astrazeneca.nl
 recruitment.nl@astrazeneca.com

Astra Tech B.V.
P.O. Box 656, NL-2700 AR Zoetermeer
The Netherlands
Tel: +31 79 360 19 50
Fax: +31 79 362 37 48
 info.nl@astratech.com
 http://www.astratech.nl


NEW ZEALAND

AstraZeneca Limited
P.O. Box 1301, Shortland Street
Auckland
ph: +64 (0)9 623 63 00
fax: +64 (0)9 623 63 01


NORWAY

AstraZeneca AS
Innspurten 15
Oslo
Tel: 21 00 64 00
Fax: 21 00 64 08

AstraZeneca AS
Markveien 1C
5012 Bergen
Tel: 55 31 38 40
Fax: 55 32 65 19

AstraZeneca AS
Hospitalgata 6
4006 Stavanger
Tel: 51 52 01 17
Fax: 51 52 01 18

AstraZeneca AS
Solsiden, Beddingen 10, 4 etg
7014 Trondheim

AstraZeneca AS
Grönnegaten 72
9008 Tromsö
Tel: 77 60 80 90
Fax: 77 63 99 90

Astra Tech AS
Postboks 160, Lørenskog, N-1471
Tel: +47 67 92 05 50
Fax: +47 67 92 05 60
 info.no@astratech.com
 http://www.astratech.no


Country Manager Bjarne Johnson
Tel: +47 21 00 64 00
Tel 90120134
 bjarne.johnson@astrazeneca.com
General
 medinfo-norge@astrazeneca.com
 kontakt.norway@astrazeneca.com

Susanne Löfgren
 susanne.lofgren@astrazeneca.com

Brit Holmberg
 brit.holmberg@astrazeneca.com

Paal Hasvold
Tel.: +47 21 00 64 00
Fax.: +47 21 00 64 08
 paal.hasvold@astrazeneca.com

Ingela Wiklund
 ingela.wiklund@astrazeneca.com

Jorund Houg
 jorund.houg@astrazeneca.com

Anna Lena Berg
 anna-lena.berg@astrazeneca.com

Per Norlen
 per.norlen@astrazeneca.com


PERU

Av. El Derby 055 torre 2, piso 5
Lima


PHILIPPINES

AstraZeneca Pharmaceuticals (Philippines), Inc.
Km. 14 South Superhighway
1700 Paranaque City, Metro Manila
Tel: (632) 823 – 2545; 823 – 8169
Fax: (632) 821 – 9922; 824 – 1388

Tomas Realiza
 tomas.realiza@astrazeneca.com


POLAND

AstraZeneca Pharma Poland Sp. z o.o.
ul. Post?pu 18, Neptun
02-676 Warszawa
Tel. +48 (22) 874 35 00
fax +48 (22) 874 35 10
fax +48 (22) 874 59 00
 poland@astrazeneca.com
 betaloc.poland@astrazeneca.com
 rekrutacja@astrazeneca.com

Astra Tech Sp. z o.o.
ul. Or??na 58
02-937 Warszawa
Tel. +48 22 853 67 06
Fax +48 22 853 67 10
 info.pl@astratech.com

Bartosz Bednarz
 bartosz.bednarz@astrazeneca.com

Jerzy Garlicki
 jerzy.garlicki@astrazeneca.com

David Brennan
General Director
 david.brennan@astrazeneca.com


PORTUGAL

AstraZeneca Produtos Farmacêuticos, Lda.
Rua Humberto Madeira, 7
Queluz-de-Baixo, 2730-097 Barcarena
Tel: +351 214 346 100
+351 21 434 6192

AstraZeneca Produtos Farmacêuticos, Lda.
Aviz Trade Center
Rua Engº Ferreira Dias, nº 924, 1º Andar, E17
4100-246 Porto
Tel: +351 229 398 030

Corporate Affairs, Media
 CorporateAffairs.Portugal@astrazeneca.com
Tel: + 351 214 346 113 / 27

 patientsafety.portugal@astrazeneca.com
Tel: +351 214 345 743
Fax: +351 214 346 177

 infomed.pt@astrazeneca.com
Tel: + 351 214 345 732

 direccao.tecnica@astrazeneca.com
Tel: + 351 214 346 137

 apoio.cliente@astrazeneca.com
Tel: + 351 214 345 779
Tel: + 351 214 345 777
Fax: + 351 214 346 161

Finance Dep.
 ap.portugal@astrazeneca.com

 EBSAPPortugal@astrazeneca.com
Tel: 0800 844 377

Human Resources
 hrptaz@astrazeneca.com

Eduardo Recoder
Marketing Company President
 eduardo.recoder@astrazeneca.com


RUSSIA

AstraZenenca
Vavilova Str., 24, block 1
Moscow 119334
Tel: +7 495 799 5699
Fax: +7 495 799 5698.
 http://www.astrazeneca.ru/
 SUMTjob@astrazeneca.com


SLOVAKIA

Astra Zeneca AB, o.z.
Lazaretska 8
811 08 Bratislava

Tel: + 421 2 5737 7777
Fax: + 421 2 5737 7778
 infoservis.sk@astrazeneca.com

Miroslav Lednar
Medical & Government Affairs Director
 miroslav.lednar@astrazeneca.com

Maria Garayova
 maria.garayova@astrazeneca.com

Dr. Milan Lopasovsky
SCORPIO INTERNATIONAL SRO
Frana Krala 1
811 01 Bratislava
Tel: ++ 421 2 54417841
Fax: ++ 421 2 54417853
 milan.lopasovsky@astrazeneca.com


SOUTH AFRICA

Beverley Dickason
Tel 011 797 6243
Fax 011 797 6019
 beverly.dickason@astrazeneca.com

Juliet Sellschop
Tel 011 797 6081
Fax 011 797 6019
 juliet.sellschop@astrazeneca.com


SPAIN

AstraZeneca Farmaceutica Spain S.A.
C/Serrano Galvache, 56, C. E. Parque Norte, Edificio Roble
Madrid 28033
ph: +34 91 301 91 00
fax: +34 91 301 91 01
 spain.recruitment@astrazeneca.com
 http://www.astrazeneca.es

AstraZeneca
La Relva s/n, Porriño (Pontevedra), 36400
ph: +34 986 345 200
fax: +34 986 345 201
 http://www.astrazeneca.es

Astra Tech S.A.
Ciencias, 73 dcha. Nave 9
Polígono Industrial Pedrosa, ES-08908 L'Hospitalet de Llobregat, Barcelona
Spain
Tel: +34 932 643 560
Fax: +34 933 363 231
 info.es@astratech.com
 http://www.es.astratech.com


Paul Hudson
President
 paul.hudson@astrazeneca.com

Sonia Cal
 sonia.cal@astrazeneca.com

Guillermo de Juan
Director Legal affairs
 guillermo.dejuan@astrazeneca.com

Luis Massa
Director
 luis.massa@astrazeneca.com

Ana Ponzoda
Financial Director
 ana.ponzoda@astrazeneca.com

Jesus Ponce
Director
 jesus.ponce@astrazeneca.com

Ines Margalet
Medical Director
 ines.margalet@astrazeneca.com

Federico Fuchs
Director
 federico.fuchs@astrazeneca.com

Federico Plaza
Director
 federico.plaza@astrazeneca.com

Miriam Moreno-Manzanaro
Medical Department, AstraZeneca Pharmaceuticals
Serrano Galvache 56
28033 Madrid
 miriam.moreno-manzanaro@astrazeneca.com

Esteban Medina
Medical Department, AstraZeneca Pharmaceuticals
Serrano Galvache 56
28033 Madrid
 esteban.medina@astrazeneca.com

Rosario Marazuela
Health Economics & Pricing Manager, Medical Department
Tel: +34 91 301 9062
Fax: +34 91 301 9104
 rosario.marazuela@astrazeneca.com


SWEDEN

AstraZeneca AB
SE-151 85
Södertälje
Tel: +46 (0)8 553 260 00
Fax: +46 (0)8 553 290 00
 SwedenRecruitment@astrazeneca.com
 lakemedelsinformation@astrazeneca.com

Astra Tech AB
Box 14
431 21 Mölndal
Tel: +46 (0)31-776 30 00
Fax: +46 (0)31-776 30 17
Fax: +46 (0)31 776 30 10
Fax: +46 31 776 30 23
 infomaster@astratech.com
 export.se@astratech.com
 info.se@astratech.com
 http://www.astratech.se


Ann-Leena Mikiver
Press officer
Mobile: +46 707 428 836
Tlf: +46 855 326 020
 ann-leena.mikiver@astrazeneca.com

Anne-Charlotte Knutsson
Tel +46 8 553 213 75 or +46 70 685 4295
 anne-charlotte.knutsson@astrazeneca.com

Anna Carbin-Ahlund
Press contact
Tel: +46 855 326 939
 anna.carbin-ahlund@astrazeneca.com

Dag Nilsson
 dag.nilsson@astrazeneca.com

Gunnar Olsson
Chairman R&D
Tel: +46 31 776 14 02
Fax: +46 31 776 38 54
 gunnar.o.olsson@astrazeneca.com

Eva Hurt-Camejo
Associate director R&D, Cell Biology & Biochemistry
Tel: +46 31 342 17 33
Fax: +46 31 82 37 62
 eva.hurt-camejo@astrazeneca.com

Dr. Hans-Georg Beisel
Research Scientist Computational Chemistry
Medicinal Chemistry
AstraZeneca R&D Mölndal
431 83 Mölndal
Tel.: +46 31 706 47 27
Fax :+46 31 776 37 10
 hans-georg.beisel@astrazeneca.com

Kasra Afsarinejad
T +46-31-776 1619
F +46-31-776 380
 kasra.afsarinejad@astrazeneca.com

Dr. Olivier Guilbaud
T +46-8-55329146
F +46-8-55328947
 olivier.guilbaud@astrazeneca.com

Saga Johansson
R&D
 saga.johansson@astrazeneca.com

Per Svensson
Phone +46 8 55321036
Fax +46 8 55328907
 per.h.svensson@astrazeneca.com

Mari-Ann Wallander
R&D
 mari-ann.wallander@astrazeneca.com

Silke Klick, PhD
R&D
Tel. +46 31 7761758
Fax +46 31 7767337
 silke.klick@astrazeneca.com

Nicholaas Schipper
Tel: +46 8 553 21 649
Fax: +46 8 553 25 080
 nicolaas.schipper@astrazeneca.com

Margareta Bielenstein, AstraZeneca
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 margareta.bielenstein@astrazeneca.com

Anna Ollerstam
Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs; J Pharmacol Toxicol Methods 2006 Mar-Apr; 53(2) :174-83; detail: concentrations and effect in conscious beagle dogs in the assessment of drug safety
 anna.ollerstam@astrazeneca.com

Orest Lastow
R&D
Tel: +46 46336925
Fax: +46 46337785
 orest.lastow@astrazeneca.com

Ratan Bhat
Tel. 46-8-553-29207
Fax: 46-8-553-21560
 ratan.bhat@astrazeneca.com

Yafeng Xue
 yafeng.xue@astrazeneca.com

Stefan Berg
 stefan.berg@astrazeneca.com

Sven Hellberg
 sven.hellberg@astrazeneca.com

Mats Ormö
 mats.ormoe@astrazeneca.com

Yvonne Nilsson
 yvonne.nilsson@astrazeneca.com

Ann-Cathrin Radesäter
 ann-cathrin.radesaeter@astrazeneca.com

Eva Jerning
 eva.jerning@astrazeneca.com

Per-Olof Markgren
 per-olof.markgren@astrazeneca.com

Thomas Borgegard
 thomas.borgegard@astrazeneca.com

Martin Nylöf
 martin.nylof@astrazeneca.com

Johan Malmström
 johan.malmstrom@astrazeneca.com

Henrik Lindberg
 henrik.lindberg@astrazeneca.com

Claes Lindberg
 claes.lindberg@astrazeneca.com

Charlotte Bratt
 charlotte.bratt@astrazeneca.com

Elisabet Wieslander
 elisabet.wieslander@astrazeneca.com

Eva-Lena Delander
 eva-lena.delander@astrazeneca.com

Bengt Särnstrand
 bengt.sarnstrand@astrazeneca.com

Jorge S. Burns
 jorge.burns@astrazeneca.com

Peter Mose-Larsen
 peter.mose-larsen@astrazeneca.com

Stephen Fey
 stephen.fey@astrazeneca.com

György Marko-Varga
Tel. +46-46-336887
Fax +46-46-337164
 gyorgy.marko-varga@astrazeneca.com

Per-Henrik Zingmark
Senior Research Scientist
Phone: +46 8 553 239 42
Fax +46 8 553 288 96
 per-henrik.zingmark@astrazeneca.com

Mats Ögren
Tel: +46 70 972 7030
Fax +46 31 776 3745
 mats.ogren@astrazeneca.com

David Bergqvist
 david.bergqvist@astrazeneca.com


SWITZERLAND

AstraZeneca AG
Grafenau 10
6301 Zug
Tel: +41 (0)41 725 7575
Fax +41 (0)41 725 7676
 info@astrazeneca.ch,  schizophrenie@astrazeneca.ch,  azpoch@astrazeneca.com,  cns@astrazeneca.ch,  gastro@astrazeneca.com

Astra Tech SA
Avenue de Sévelin 18
1004 Lausanne
Tel: +41 21 620 0230
Fax: +41 21 620 0231
 info.ch@astratech.com
 http://www.astratech.ch

Dirk Schneider
Director
German citizen
 dirk.schneider@astrazeneca.com

Schneider, Dirk
Fustlighalde 10
4600 Olten/SO
+41 62 212 16 41

Annette Veltmar
CEO, German citizen, vivisector!
 annette.veltmar@astrazeneca.com

Veltmar, Annette
Zugerstr. 38
8810 Horgen/ZH
+41 43 244 60 13

Brain Research, Volume 569, Issue 1, 8 January 1992, Pages 117-122: Thilo Stadler*, Annette Veltmar, Fatimunnisa Qadri and Thomas Unger: Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats


Sonja Salmi
Director, Finnish citizen
 sonja.salmi@astrazeneca.com

Silvia Perucchi
Director, Regulatory and QA Manager
Tel +41 41 725 74 58
 silvia.perucchi@astrazeneca.com

Silvia Perucchi
A Ra Tur
6945 Origlio/TI
+41 91 945 13 49

Silvia Perucchi
St.-Johannes-Strasse 25
6300 Zug
+41 41 740 51 59

Dominique Jagmetti
Director
 dominique.jagmetti@astrazeneca.com

Dominique Jagmetti
Seefeldstrasse 92
8008 Zürich
+41 44 364 34 14

Marcus Kaeller
Board member
Home: Germany, Netherlands
Residence: Richmond (GB)
 marcus.kaeller@astrazeneca.com

Urban Skog
Board member, Swedish
 urban.skog@astrazeneca.com

Urban Skog
Dürrenburgstrasse 3b
6318 Walchwil/ZG
+41 41 758 10 15

Rolf Zwygart
Corporate Affairs Director
Tel direkt: +41 41 725 70 00
mobile +41 79 415 49 03
Fax: +41 41 725 71 71
 rolf.zwygart@astrazeneca.com

Rolf Zwygart
Höraaweg 5, 8477 Oberstammheim/ZH
+41 52 745 19 46

Nadia Staub
Tel. +41 41 725 74 51
 nadia.staub@astrazeneca.com

Marc Schneider
 marc.schneider@astrazeneca.com

Schneider, Marc
Rotmattstrasse 13
6045 Meggen/LU
+41 41 377 39 39

Sabine Schneitter-Rieder
Business Unit Manager CNS
Tel. +41 (0)41 725 75 75
 sabine.schneitter@astrazeneca.com

Sabine Schneitter-Rieder
Schädrütihalde 39
6006 Luzern
+41 41 370 91 92

Gerhard Stucki
Mobile 079 446 61 22
 gerhard.stucki@astrazeneca.com

Carlo Meybohm
Product Manager Central Nervous System
 carlo.meybohm@astrazeneca.com

Carlo Meybohm
Heinrich Wettsteinstrasse 12
8700 Küsnacht/ZH
Tel +41 43 344 97 70

Jacqueline Spieler
 jacqueline.spieler@astrazeneca.com

Katharina Fahrenkrog
 katharina.fahrenkrog@astrazeneca.com

Anna-Barbara Bärtschi
 anna-barbara.baertschi@astrazeneca.com

Sandra Stöckenius
Brand Manager CNS
Tel. +41 41 725-7803
 sandra.stoeckenius@astrazeneca.com

Sabrina Gujer
 sabrina.gujer@astrazeneca.com

Gujer, Sabrina
Chilerai 33
8602 Wangen/ZH
+41 44 834 00 84

Martina Leiva
Tel. +41 (0) 41 725 74 51
 martina.leiva@astrazeneca.com


UK

AstraZeneca
2 Kingdom Street
Paddington
London
W2 6BD
Tel +44(0)20 7604 8000
Tel:+44 (0)20 7304 5000
Fax:+44 (0)20 7304 5151
 HRConnectUK@astrazeneca.com

AstraZeneca
Emerging Markets Support & Development Organisation
Silk Court, Hulley Road, Silk Road Business Park
Macclesfield
Cheshire SK10 2NA
Tel:+44 (0)1625 582828
Fax:+44 (0)1625 586296

AstraZeneca Alderley House
Alderley Park, Macclesfield
Cheshire
SK10 4TF
Tel:+44 (0)1625 582 828
Fax:+44 (0)1625 516 658

AstraZeneca European Business Services
Renaissance Court, Christie Fields Office Park, Derwent Avenue, Chorlton-cum-Hardy
M21 7QS
Manchester
Tel: +44 (0)1625 582828
Fax: +44 (0)1625 230 512

AstraZeneca Global Intellectual Property
15 Stanhope Gate
London
W1K 1LN
Tel:+44 (0)20 7304 5000
Fax:+44 (0)20 7304 5151

AstraZeneca Operations & Business Services
Middlewood Suite, Block 204, Charter Way, Macclesfield, Silk Road Business Park
Cheshire SK10 2NX
Tel:+44 (0) 1625 582828
Fax:+44 (0) 1625 619637

AstraZeneca R&D Alderley Park
Alderley Park, Macclesfield
SK10 4TF
Cheshire
Tel:+44 (0)1625 582 828
Fax:+44 (0)1625 516 658 (Alderley House)
+44 (0)1625 583 074 (Mereside)

AstraZeneca R&D Charnwood
Bakewell Road, Loughborough
Leicestershire LE11 5RH
Tel:+44 (0)1509 64 4000
Fax:+44 (0)1509 64 5555

AstraZeneca UK Clinical Research Group
7 Lochside Avenue Edinburgh Park
Edinburgh EH12 9DJ
Tel:+44 (0)131 317 2000
Fax:+44 (0)131 317 2111

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton,
LU1 3LU
Bedfordshire
Tel:+44 (0)1582 836000
Fax:+44 (0)1582 838000

AstraZeneca UK Limited
Brixham Environmental Laboratory Freshwater Quarry Brixham
Devon
TQ5 8BA
Tel:+44 (0)1803 882 882
Fax:+44 (0)1803 882 974

Avlon Works
Severn Road Hallen
Bristol BS10 7ZE
Tel:+44 (0)117 938 2999

Cambridge Antibody Technology
Milstein Building, Granta Park
Cambridge
CB21 6GH
Tel:+44 (0)1223 471 471
Fax:+44 (0)1223 471 472

Kudos Pharmaceuticals Ltd
410 Cambridge Science Park
Cambridge
CB4 0PE
Tel:+44 (0) 1223 719 719
Fax:+44 (0) 1223 719 720
www.kudospharma.co.uk

Astra Tech Ltd. (UK) - including Eire
Brunel Way, Stonehouse
Gloucestershire GL10 3SX
Tel:+44 (0)1453 79 1763
Fax:+44 (0)1453 79 1001
 info.uk@astratech.com
 http://www.astratechuk.com


Louis Schweitzer
Chairman
 louis.schweitzer@astrazeneca.com

Neil McCrae
Media Inquiries, UK
Tel +44-20-7604-8236
 neil.mccrae@astrazeneca.com

Sarah Lindgreen
Media Inquiries, UK
Tel +44-20-7604-8033
 sarah.lindgreen@astrazeneca.com

Abigail Baron
Media Inquiries, UK
Tel +44-20-7604-8034
 abigail.baron@astrazeneca.com

Esra Erkal-Paler
Media Inquiries
Tel +44 20 7604 8032
 esra.erkal-paler@astrazeneca.com

Jonathan Hunt
Investor Inquiries
Tel +44-20-7604-8122
 jonathan.hunt@astrazeneca.com

Nicklas Westerholm
Tel +44 20 7604 8124
 nicklas.westerholm@astrazeneca.com

Karl Hard
Investor Inquiries
Tel +44-20-7604-8123
 karl.hard@astrazeneca.com

Matti Ojanen
Director, International Affairs and Public Policy
 matti.ojanen@astrazeneca.com

Susan Blewett
Alderley House
Tel: +44 1625 513560
Fax: +44 1625 582912
 susan.blewett@astrazeneca.com

Prof. Barry Furr
O.B.E. Chief Scientist and Head of Project Evaluation Group
Alderley Park
Tel: + 44 1625 514875
Fax: + 44 1625 590115
 barry.furr@astrazeneca.com

Channeary I. McDowell
 channeary.mcdowell@astrazeneca.com

Dr. Gordon France
Vice President, Strategy, Technology & Systems, Pharmaceutical and Analytical R&D, AstraZeneca R&D Chamwood
Phone +44-0-150-964-4780
Fax +44-0-150-964-5528
 gordon.france@astrazeneca.com

Frances Charlesworth
Director -Global Government Affairs & Policy
Tel: + 44 207 304 5287/88
 frances.charlesworth@astrazeneca.com

Dr. Jean-Pierre Valentin
Tel: +44 1625 513202
Fax: +44 1625 515783
 jean-pierre.valentin@astrazeneca.com

Mina Blair
Tel +44-20-7304-5084
 mina.blair@astrazeneca.com

Dr Jeremy Parker
 jeremy.parker@astrazeneca.com

Dr. Tim Hammond
Tel: +44 1625 514810
Fax: +44 1625 513779
 tim.hammond@astrazeneca.com

David Laffan
Researcher
Fax: +44 (0)1625 500780
Tel: +44 (0)1625 517483
 dave.laffan@astrazeneca.com

Colin Thomson
Fax: 44 (0)1509 645588
Tel: 44(0)1509 644273
 colin.thomson@astrazeneca.com

Dr Campbell Wilson
Tel: 01625 513238
Fax: 01623 519749
 campbell.wilson@astrazeneca.com

Dave J. Vosvenieks
Tel +44 1625 517 680
Fax +44 1625 513 512
 dave.vosvenieks@astrazeneca.com
Teresa Klinowska
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
Tel: 44-1625-513086
Fax: 44-1625-513624
 teresa.klinowska@astrazeneca.com

Dr Andrew M. Hughes
Experimental Medicine Group, Alderley Park
Tel: 01625 512092
Fax: 01625 585626
 andrew.hughes@astrazeneca.com

Huw B. Jones
Scientist, Experiments: Diabetic Nephropathy and Long-Term Treatment Effects of Rosiglitazone and Enalapril in Obese ZSF1 Rats: At 8 weeks of age, obese rats developed metabolic syndrome and diabetes. By 32 weeks of age, animals developed renal histopathology including liver and kidney injury
 http://joe.endocrinology-journals.org/content/early/2011/06/16/JOE-11-0122.abstract
 huw.jones@astrazeneca.com

Rachel M. Mayers
Scientist, Experiments: Diabetic Nephropathy and Long-Term Treatment Effects of Rosiglitazone and Enalapril in Obese ZSF1 Rats: At 8 weeks of age, obese rats developed metabolic syndrome and diabetes. By 32 weeks of age, animals developed renal histopathology including liver and kidney injury
 http://joe.endocrinology-journals.org/content/early/2011/06/16/JOE-11-0122.abstract
 rachel.mayers@astrazeneca.com

Simon M. Poucher
Scientist, Experiments: Diabetic Nephropathy and Long-Term Treatment Effects of Rosiglitazone and Enalapril in Obese ZSF1 Rats: At 8 weeks of age, obese rats developed metabolic syndrome and diabetes. By 32 weeks of age, animals developed renal histopathology including liver and kidney injury
 http://joe.endocrinology-journals.org/content/early/2011/06/16/JOE-11-0122.abstract
 simon.poucher@astrazeneca.com

Georgina Speake
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Experiments were conducted on 8- to 12-wk-old female mice
 georgina.speake@astrazeneca.com

John Vincent
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
 john.vincent@astrazeneca.com

Cath Trigwell
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
 cath.trigwell@astrazeneca.com

Judith Anderton
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
 judith.anderton@astrazeneca.com

Sarah Beck
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
 sarah.beck@astrazeneca.com

Gayle Marshall
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
 gayle.marshall@astrazeneca.com

Sara Davenport
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Ex-
periments were conducted on 8- to 12-wk-old female mice
 sara.davenport@astrazeneca.com

Rowena Callis
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Experiments were conducted on 8- to 12-wk-old female mice
 rowena.callis@astrazeneca.com

Elizabeth Mills
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Experiments were conducted on 8- to 12-wk-old female mice
 elizabeth.mills@astrazeneca.com

Paul Smith
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Experiments were conducted on 8- to 12-wk-old female mice
 paul.smith@astrazeneca.com

Robert W. Wilkinson
(Charles River) mice were housed in negative-pressure isolators
(PFI Systems Ltd.) at Alderley Park, United Kingdom. Experiments were conducted on 8- to 12-wk-old female mice
 robert.wilkinson@astrazeneca.com

Annabelle Heier
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
Tel: +44-1625-510869
Fax: +44-1625-514812
 annabelle.heier@astrazeneca.com

Sally Price
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 sally.a.price@astrazeneca.com

Daniel I. Heathcote
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 dan.heathcote@astrazeneca.com

Kristin Samuelsson
Experiments: Assessment of mice with humanized livers
 kristin.samuelsson@astrazeneca.com

Kathryn Pickup
Experiments: Assessment of mice with humanized livers
 kathryn.pickup@astrazeneca.com

John Swales
Experiments: Assessment of mice with humanized livers
 john.swales@astrazeneca.com

James Yates
Experiments: Assessment of mice with humanized livers
 james.yates@astrazeneca.com

Christopher Smith
Experiments: Assessment of mice with humanized livers
 christopher.smith@astrazeneca.com

Richard Gallagher
Experiments: Assessment of mice with humanized livers
 richard.gallagher@astrazeneca.com

Ian Wilson
Experiments: Assessment of mice with humanized livers
 ian.wilson@astrazeneca.com

Dr Hussain Mulla
Department of Clinical Pharmacology, R & D
Tel: +44 (0)1509 644249
Fax: +44 (0) 1509 645514
 hussain.mulla@astrazeneca.com

Neil Carragher
Advanced Science and Technology Laboratory, R&D Charnwood
Phone: 440-1509645408
Fax: 440-1509647709
 neil.carragher@astrazeneca.com

Peter D. Caie
 peter.caie@astrazeneca.com

Rebecca E. Walls
 rebecca.walls@astrazeneca.com

Joachim Grevel
Tel +44 (0) 1509 644035
Fax +44 (0) 1509 645576
Mobile +44 (0) 7920 285905
 joachim.grevel@astrazeneca.com

Alexandra Ingleston-Orme
 alexandra.ingleston-orme@astrazeneca.com

Sandeep Daya
 sandeep.daya@astrazeneca.com

Tom Houslay
 tom.houslay@astrazeneca.com

Helen Brown
R&D Charnwood
Tel: +44. 1509 645 065
Fax: +44 1509 645 546
 helen.c.brown@astrazeneca.com

Steve Rees, Ph.D.
Tel: +01625 510004
 steve.rees@astrazeneca.com

Christine M. Chresta
Phone: 44-1625-517862
Fax: 44-1625-519749
 christine.chresta@astrazeneca.com

Barry R. Davies
 barry.davies@astrazeneca.com

Tom Harding
 tom.harding@astrazeneca.com

Sabina Cosulich
 sabina.cosulich@astrazeneca.com

Susan E. Critchlow
 susan.critchlow@astrazeneca.com

John P. Vincent
 john.vincent@astrazeneca.com

Terry Reed
Alliance Manager, Science and Technology Licensing
 terry.reed@astrazeneca.com

Rebecca Ellston
 rebecca.ellston@astrazeneca.com

Darren Jones
 darren.jones@astrazeneca.com

Patrizia Sini
 patrizia.sini@astrazeneca.com

Dominic James
 dominic.james@astrazeneca.com

Zoe Howard
 zoe.howard@astrazeneca.com

Phillippa Dudley
 phillippa.dudley@astrazeneca.com

Gareth Hughes
 gareth.hughes@astrazeneca.com

Richard Jenkins
 richard.jenkins@astrazeneca.com

Matt Jacobsen
 matt.jacobsen@astrazeneca.com

Graeme C.M. Smith
 graeme.smith@astrazeneca.com

Sylvie Guichard
 sylvie.guichard@astrazeneca.com

Martin Pass
 martin.pass@astrazeneca.com

Julie Hayes
"The rat bone marrow micronucleus test—study design and statistical power. When it was decided to change the strain of rat routinely used in this laboratory to the Han Wistar, a preliminary study was performed to investigate the possible factors influencing experimental variability. Study design is from groups of seven rats."
Tel: +44 162 551 5776
Fax: +44 162 523 1281
 julie.hayes@astrazeneca.com

Ann T. Doherty
"The rat bone marrow micronucleus test—study design and statistical power. When it was decided to change the strain of rat routinely used in this laboratory to the Han Wistar, a preliminary study was performed to investigate the possible factors influencing experimental variability. Study design is from groups of seven rats."
 ann.doherty@astrazeneca.com

Deborah J. Adkins
"The rat bone marrow micronucleus test—study design and statistical power. When it was decided to change the strain of rat routinely used in this laboratory to the Han Wistar, a preliminary study was performed to investigate the possible factors influencing experimental variability. Study design is from groups of seven rats."
 deborah.adkins@astrazeneca.com

Karen Oldman
"The rat bone marrow micronucleus test—study design and statistical power. When it was decided to change the strain of rat routinely used in this laboratory to the Han Wistar, a preliminary study was performed to investigate the possible factors influencing experimental variability. Study design is from groups of seven rats."
 karen.oldman@astrazeneca.com

Michael R. O'Donovan
"The rat bone marrow micronucleus test—study design and statistical power. When it was decided to change the strain of rat routinely used in this laboratory to the Han Wistar, a preliminary study was performed to investigate the possible factors influencing experimental variability. Study design is from groups of seven rats."
 michael.odonovan@astrazeneca.com

Marianne J. Ratcliffe
 marianne.ratcliffe@astrazeneca.com

Tim French
Tel. +44 1625-519922
 tim.french@AstraZeneca.com



USA

AstraZeneca Pharmaceuticals LP
587 Old Baltimore Pike
DE 19702
Newark
Tel:+1 302 286 3500

Fax:+1 302 286 4097
 http://www.astrazeneca-us.com

AstraZeneca PLC
1800 Concord Pike
P.O. Box 15437
Wilmington
DE 19850-5437
Tel: +1 (302) 886 3000
Fax: +1 (302) 886 2972

Astra Tech Inc. (HQ USA)
890 Winter Street, Suite 310
Waltham, MA 02451
Tel: 800-531-3481 and 781-890-6800
Fax: 781-890-6808
 customerservice.us@astratech.com
 http://www.astratechdental.us

Astra Tech Inc.
21535 Hawthorne Blvd., Suite 525
Torrance, CA 90503
Tel toll-free: (877) 4-LOFRIC (456-3742)
Tel: (310) 316-2626
Fax: (310) 316-5296
 info.urology.us@astratech.com
 http://www.astratechusa.com

US Corporate Leadership Team

Rich Fante
President AstraZeneca US, Regional VP North America
 rich.fante@astrazeneca.com

Glenn M. Engelmann
Vice President, Policy, Legal & Scientific Affairs, General Counsel
 glenn.engelmann@astrazeneca.com

Jim Helm
Vice President, Cardiovascular
 jim.helm@astrazeneca.com

Kathy Monday
Vice President, North America Operations
 kathy.monday@astrazeneca.com

David P. Nicoli
Vice President, Corporate Affairs
 david.nicoli@astrazeneca.com

Linda Palczuk
Vice President, Sales & Marketing
 linda.palczuk@astrazeneca.com

Lisa Schoenberg
Vice President, Specialty Care
 lisa.schoenberg@astrazeneca.com

David Snow
Vice President, Cornerstone Business
 david.snow@astrazeneca.com

Jayne Stanier
 jayne.stanier@astrazeneca.com

Ed Seage
Investor Inquiries
Tel +1 302-886-4065
 ed.seage@astrazeneca.com

Jorgen Winroth
Investor Inquiries
Tel +1 212-579-0506
 jorgen.winroth@astrazeneca.com

Tiffany Burke
Media Inquiries
Tel 302-885-4995
 tiffany.burke@astrazeneca.com

Shannon Miller
Tel 302-885-3623
 shannon.miller@astrazeneca.com

Tony Jewell
Media Inquiries
Tel +1-302-885-4594
 tony.jewell@astrazeneca.com

Leah Geib
Media Inquiries
Tel +1-302-885-1755
 leah.geib@astrazeneca.com

Troy Benavidez
Media Contact
Tel 302-885-0308
 troy.benavidez@astrazeneca.com

Katie Lubenow
Tel 302-885-9960
 katie.lubenow@astrazeneca.com

Emily Denney
Media Inquiries
Tel 302-885-3451
 emily.denney@astrazeneca.com

Blair Hains
Tel 302-885-1813
 blair.hains@astrazeneca.com

Rachelle Benson
Tel 302-885-5853
 rachelle.benson@astrazeneca.com

Donna Lutz
Tel 302-885-8605
 donna.lutz@astrazeneca.com

Corey Windett
Tel 302-885-0034
 corey.windett@astrazeneca.com

Laura Woodin
Media Inquiries
Tel +1 302-885-1087
 laura.woodin@astrazeneca.com

Dr. Russell Bialecki
Tel: 302-886-5356
Fax: 302-886-2341
 russell.bialecki@astrazeneca.com

Dr. Thomas Marks
Tel: 302-885-8409
Fax: 302-886-2341
 thomas.marks@astrazeneca.com

James J. Ferguson III, MD
Phone: (302) 885-8367
Mobile: (302) 824-6502
Fax: (302) 885-5342
 james.ferguson@astrazeneca.com

Jackson (Jay) Gibbs, Ph.D.
T: 781-839-4945
 jackson.gibbs@astrazeneca.com

Jim Minnick
Tel 302-886-5135
 jim.minnick@astrazeneca.com

Dr. Julien Giovannini
 julien.giovannini@astrazeneca.com

Greg Sylvestre
Phone: 204-793-9105
 greg.sylvestre@astrazeneca.com

Anne Berry
Director, Federal Alliances
Tel (202) 350-5533
Fax (202) 350-5520
 anne.berry@astrazeneca.com

Susan Ashwell
R&D
Phone: 1-781-839-4857
Fax: 1-781-839-4200
 susan.ashwell@astrazeneca.com

Sonya Zabludoff
 sonya.zabludoff@astrazeneca.com

C.J. James, R.Ph.
Professional Pharmacy Association Affairs Director
Tel (210) 494-3814
 clyde.james@astrazeneca.com

Clive Armitage
Tel: +1-302-886-3556
Fax: +1-302-886-8228
 clive.armitage@astrazeneca.com

Kenneth C. Mattes, Ph.D.
R&D Boston
Phone: +1 781-839-4649
Fax: +1 781-839-4580
 ken.mattes@astrazeneca.com

Paul J. Ciaccio
Fax: (302) 886-2341
 paul.ciaccio@astrazeneca.com

Adriane L. Spencer
Lobbyist for Astra Zeneca Pharmaceuticals
7516 Jeanette Place
New Orleans LA 70118
Phone: (504) 458-4378
Fax: (504) 866-3991
 adriane.spencer2@astrazeneca.com

Charles Carr
Regional Training and Development Leader
 charles.carr@astrazeneca.com
Mark A. Smith
M.D.
Pharmaceuticals Experimental Medicine; "adult male
rats, which had been maternally separated as infants,
displayed more anxiety-like behavior compared with
handled rats"
"Previous studies have typically found that adult rats
which had been maternally separated as infants secrete
more ACTH in response to stressors compared with
handled rats (Plotsky and Meaney 1993; Patchev et al.
1997; Ladd et al. 2000). Here we measured plasma
ACTH levels 5 min after a single footshock. Although
basal (no shock) ACTH levels were slightly higher than
one would expect, there was a significant effect of the
footshock to elevate ACTH"
(source: NEUROPSYCHOPHARMACOLOGY 2002–VOL. 26, NO. 5)
Tel.: (302) 886-5140
Fax: (302) 886-1099
 mark.a.smith@astrazeneca.com

Mausumee Guha
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 mausumee.guha@astrazeneca.com

Robert G. Caccese
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 robert.caccese@astrazeneca.com

Thomas R. Simpson
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 thomas.simpson@astrazeneca.com

David B. Stong
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
 david.stong@astrazeneca.com

Elmarie Bodes
Experiments: Assessment of Biomarkers of Drug-induced Kidney Injury in Cynomolgus Monkeys
Tel: +1-302-885-6989
Fax: +1-302-886-1400
 elmarie.bodes@astrazeneca.com

Lilian G. Yengi
Tel:(781) 472 5984
Fax: (781) 472-5926
 lilian.yengi@astrazeneca.com

Charlie Gillean
Ph 302-886-1183
Fax 302-886-5155
 charles.gillean@astrazeneca.com

Vance Warren
Tel: (302) 885-1683
Fax: (302) 886-1512
 vance.warren@astrazeneca.com

Ken Fasman, Ph.D.
Vice President, R&D Informatics
Tel (781) 839-4518
Fax (781) 839-4500
 ken.fasman@astrazeneca.com

Sue Schultz
Phone 302-885-1560
Fax: 302-886-7259
 suzette.schultz@astrazeneca.com

Charles Gillean
Small Business Liaison Officer
Tel (302) 886-1183
 charles.gillean@astrazeneca.com

Adrian M. Senderowicz
R&D, Clinical Development, Oncology
Phone: 302-885-1513
Fax: 302-886-2622
 adrian.senderowicz@astrazeneca.com

Boudewijn de Jonge
Phone: (781) 839-4535
Fax: (781) 839-4500
 boudewijn.dejonge@astrazeneca.com

Peter R. Bernstein, Ph.D.
Tel (302) 886-8966
 bernstein9@aol.com
 peter.bernstein@astrazeneca.com

Kathleen Zemanek
account director
 kathleen.zemanek@astrazeneca.com


ALL EMAILS FOR ASTRAZENECA (including more not listed above)

 jon.symonds@astrazeneca.com,  tony.zook@astrazeneca.com,  bruno.angelici@astrazeneca.com,  barrie.thorpe@astrazeneca.com,  jan.lundberg@astrazeneca.com,  tony.b.loxham@astrazeneca.com,  peter.bonfield@astrazeneca.com,  christopher.sampson@astrazeneca.com,  louise.marland@astrazeneca.com,  asa.c.pehrsson@astrazeneca.com,  heinz.wechner@astrazeneca.com,  sabine.schneitter@astrazeneca.com,  schizophrenie@astrazeneca.ch,  cns@astrazeneca.ch,  patrick.steinmetz@astrazeneca.com,  maria-teresa.fernandez@astrazeneca.com,  monika.elsener@astrazeneca.com,  jacqueline.spieler@astrazeneca.com,  karin.broger@astrazeneca.com,  azpoch@astrazeneca.com

 antje.thesenvitz@astrazeneca.com,  azone@astrazeneca.com,  informacio.hu@astrazeneca.com,  brita.merisalu@astrazeneca.com,  sofia.peterson@astrazeneca.com,  jenny.engstrom@astrazeneca.com,  helena.krieg@astrazeneca.com,  daga.jonsson@astrazeneca.com,  mattias.bergqvist@astrazeneca.com,  iressa@astrazeneca.ch,  info@astratech.com,  janet.caldwell@astrazeneca.com,  medical.informationuk@astrazeneca.com,  azukwebmaster@astrazeneca.com,  psl.alderley@astrazeneca.com,  tres@astrazeneca.com,  hrconnectrecruitmentadminuk@astrazeneca.com,  christopher.dalton@astrazeneca.com,  gill.hilsdon@astrazeneca.com

 rhona.allgood@astrazeneca.com,  hrconnectuk@astrazeneca.com,  heather.derrick@astrazeneca.com,  wendy.priest@astrazeneca.com,  emily.denney@astrazeneca.com,  steven.gray@astrazeneca.com,  ismoukfeedback@astrazeneca.com,  helen.hayes@astrazeneca.com,  ismoukpress@astrazeneca.com,  infomaster@astrazeneca.com,  recruitmentcz@astrazeneca.com,  marie-noelle.maire@astrazeneca.com,  az.staffing@astrazeneca.com,  healthyvolunteers@astrazeneca.com,  anja.hegt@astrazeneca.com,  pal.deberitz@astrazeneca.com,  james.ferguson@astrazeneca.com

 kontaktskjema.legemiddelstudier.no@astrazeneca.com,  produktinformation@astrazeneca.com,  niclas.holm@astrazeneca.com,  infomaster.brixham@astrazeneca.com,  ann-christine.berg@astrazeneca.com,  forsoksperson.hs@astrazeneca.com,  cpu.web@astrazeneca.com,  lotta.sjosten@astrazeneca.com,  elearning.alderleypark@astrazeneca.com,  student@astratech.com,  info.nl@astrazeneca.com,  webmaster.finland@astrazeneca.com,  anders.damgaard@astrazeneca.com,  gastrosource.info@astrazeneca.com,  press.office@astrazeneca.com,  information.center@astrazeneca.com,  info.hlab@astrazeneca.com,  astrazenecaar@astrazeneca.com,  customer.serviceau@astrazeneca.com,  infomaster.australia@astrazeneca.com

 webmaster-be@astrazeneca.com,  medinfo.canada@astrazeneca.com,  customer.relations1@astrazeneca.com,  infomastercanada1@astrazeneca.com,  privacy.inquiries@astrazeneca.com,  infoservis.cz@astrazeneca.com,  jan.waclav@astrazeneca.com,  zdenek.pokorny@astrazeneca.com,  alexane.gurwic@astrazeneca.com,  info@astrazeneca.de,  astrazeneca.india@astrazeneca.com,  azrefi@astrazeneca.com,  anjali.chandavarkar@astrazeneca.com,  emese.majorosi@astrazeneca.com,  betty.lanyi@astrazeneca.com,  info@astrazeneca.hu,  jobdk@astrazeneca.com,  charlotte.zarp-andersson@astrazeneca.com,  infomaster.dk@astrazeneca.com,  ledigatjanster.forvaltning@astrazeneca.com,  nanna.dam@astrazeneca.com,  webmaster.dk@astrazeneca.com,  med.info@astrazeneca.com,  anne.brandt@astrazeneca.com

 info.be@astrazeneca.com,  be-medicalinfo@astrazeneca.com,  david.ingason@astrazeneca.com,  andrea.ingimundardottir@astrazeneca.com,  bjarnfridur.gudmundsdottir@astrazeneca.com,  hronn.hardardottir@astrazeneca.com,  olafur.olafsson@astrazeneca.com,  gunnur.thorsdottir@astrazeneca.com,  stefania.snorradottir@astrazeneca.com,  lisa.petursdottir@astrazeneca.com,  thomas.ewertsen@astrazeneca.com,  inger.heggebo@astrazeneca.com,  bjorn.eirik.kirkeberg@astrazeneca.com,  anne-hilde.rosvik@astrazeneca.com,  birgitta.andersson2@astrazeneca.com,  knut.hugdal@astrazeneca.com,  katarina.lundh@astrazeneca.com,  svein.morten.ertsaas@astrazeneca.com,  mona.strom.arnoy@astrazeneca.com,  stilling@astrazeneca.com,  medinfo-norge@astrazeneca.com

 firmapost@astrazeneca.com,  ebiz-support@astrazeneca.com,  recruitment.nl@astrazeneca.com,  astrazeneca.turkey@astrazeneca.com,  contact.th@astrazeneca.com,  studentinfo@astrazeneca.com,  bjorn.cederlund@astrazeneca.com,  younjung.kang@astrazeneca.com,  suejung.lee@astrazeneca.com,  huw.jones@astrazeneca.com,  rachel.mayers@astrazeneca.com,  simon.poucher@astrazeneca.com,  wayne.quigley@astrazeneca.com

 webmaster.korea@astrazeneca.com,  annabel.steuart-corry@astrazeneca.com,  steve.brown@astrazeneca.com,  edel.mccaffrey@astrazeneca.com,  judy.wang@astrazeneca.com,  compliance.connection@astrazeneca.com,  estonia@astrazeneca.com,  azgrcontactus@astrazeneca.com,  azgrcareers@astrazeneca.com,  azgrwebmaster@astrazeneca.com,  sirpa.ahtila@astrazeneca.com,  lasse.savonen@astrazeneca.com,  mikko.fernstrom@astrazeneca.com,  marco.hautalahti@astrazeneca.com,  harri.leiviska@astrazeneca.com,  sakari.markus@astrazeneca.com,  seija.pitkanen@astrazeneca.com,  reijo.sokura@astrazeneca.com,  klaus.tamminen@astrazeneca.com,  medinfo.finland@astrazeneca.com

 mette.lindstrom@astrazeneca.com,  irelandinfo@astrazeneca.com,  helle.v.seistrup@astrazeneca.com,  susanne.g.straede@astrazeneca.com,  rasmus.toft@astrazeneca.com,  astrazeneca.lithuania@astrazeneca.com,  cat.barnett@astrazeneca.com,  danielle.dols@astrazeneca.com,  rekrutacja@astrazeneca.com,  infopl@astrazeneca.com,  astrazeneca.uruguay@astrazeneca.com

 simon.lowth@astrazeneca.com,  david.smith@astrazeneca.com,  jan.lundberg@astrazeneca.com,  lynn.tetrault@astrazeneca.com,  investor@arrowt.co.uk,  jobs@arrowt.co.uk,  info@arrowt.co.uk,  scockerill@arrowt.co.uk,  sgrieve@arrowt.co.uk,  dtait@arrowt.co.uk,  kpowell@arrowt.co.uk,  HR@Arrowt.co.uk,  info@kudospharma.co.uk,  hr@kudospharma.co.uk,  nmartin@kudospharma.co.uk,  mjoconnor@kudospharma.co.uk,  ASlade@kudospharma.co.uk

 info@astrazeneca.ch,  silvia.perucchi@astrazeneca.com,  rolf.zwygart@astrazeneca.com,  nadia.staub@astrazeneca.com,  sabine.schneitter@astrazeneca.com,  gerhard.stucki@astrazeneca.com,  katharina.fahrenkrog@astrazeneca.com,  sandra.stoeckenius@astrazeneca.com,  sabrina.gujer@astrazeneca.com,  martina.leiva@astrazeneca.com,  schizophrenie@astrazeneca.ch,  azpoch@astrazeneca.com,  cns@astrazeneca.ch,  gastro@astrazeneca.com,  dirk.schneider@astrazeneca.com,  annette.veltmar@astrazeneca.com,  sonja.salmi@astrazeneca.com,  dominique.jagmetti@astrazeneca.com,  marcus.kaeller@astrazeneca.com,  urban.skog@astrazeneca.com,  marc.schneider@astrazeneca.com,  carlo.meybohm@astrazeneca.com,  jacqueline.spieler@astrazeneca.com

 peter.schiffer@astrazeneca.com,  astrid.holmas@astrazeneca.com,  abigail.baron@astrazeneca.com,  david.nicoli@astrazeneca.com,  joris.silon@astrazeneca.com,  petr.divis@astrazeneca.com,  maria.garayova@astrazeneca.com,  yvonne.lorenz@astrazeneca.com,  arthur.lazarus@astrazeneca.com,  jorgen.winroth@astrazeneca.com,  rich.fante@astrazeneca.com,  jan.baer@astrazeneca.com,  info.at@astrazeneca.com,  webmaster.at@astrazeneca.com,  frank.mitterer@astrazeneca.com,  HR.be@astrazeneca.com,  dataprivacy.belgium@astrazeneca.com,  patientsafety.belgium@astrazeneca.com,  Secretariat.FoundationBelgium@astrazeneca.com

 reception.sofia@astrazeneca.com,  zoya.paunova@astrazeneca.com,  milena.evrova@astrazeneca.com,  stoyanka.muhovska@astrazeneca.com,  RHSelecao@astrazeneca.com,  customer.relations1@astrazeneca.com,  RecruitmentCA@astrazeneca.com,  michael.cloutier@astrazeneca.com,  william.charnetsky@astrazeneca.com,  carlo.mastrangelo@astrazeneca.com,  kirsten.evraire@astrazeneca.com,  katie.lubenow@astrazeneca.com,  stephanie.batcules@astrazeneca.com,  daniela.cohen@astrazeneca.com,  jennifer.mccormack@astrazeneca.com,  alison.pozzobon@astrazeneca.com,  lee.rammage@astrazeneca.com,  michelle.riccio@astrazeneca.com


 recruitment.china@astrazeneca.com,  recepce@astrazeneca.com,  infoservis.cz@astrazeneca.com,  czdrugsafety@astrazeneca.com,  robert.weigl@astrazeneca.com,  jan.baer@astrazeneca.com,  nadiavega.vasiljev@astrazeneca.com,  rekrytointi@astrazeneca.com,  recrutement.france@astrazeneca.com,  HR-OPS.Germany@astrazeneca.com,  gabriel.baertschi@astrazeneca.com,  henning.wrogemann@astrazeneca.com,  claus.runge@astrazeneca.com,  stefan.busch@astrazeneca.com,  bernd.friedrich@astrazeneca.com,  thomas.gartz@astrazeneca.com,  kai.richter@astrazeneca.com,  carsten.nowotsch@astrazeneca.com,  doris.mayer@astrazeneca.com,  dirk.greshake@astrazeneca.com

 presse@astrazeneca.com,  kerstin.heinemann@astrazeneca.com,  friedrich.vonheyl@astrazeneca.com,  tanjore.balganesh@astrazeneca.com, HRLearning.Development& Staffing@astrazeneca.com,  reclutamiento-mexico@astrazeneca.com,  bjarne.johnson@astrazeneca.com,  susanne.lofgren@astrazeneca.com,  brit.holmberg@astrazeneca.com,  paal.hasvold@astrazeneca.com,  ingela.wiklund@astrazeneca.com,  jorund.houg@astrazeneca.com,  anna-lena.berg@astrazeneca.com,  per.norlen@astrazeneca.com,  poland@astrazeneca.com,  betaloc.poland@astrazeneca.com,  rekrutacja@astrazeneca.com,
 bartosz.bednarz@astrazeneca.com,  jerzy.garlicki@astrazeneca.com

 david.brennan@astrazeneca.com,  SUMTjob@astrazeneca.com,  infoservis.sk@astrazeneca.com,  miroslav.lednar@astrazeneca.com,
 spain.recruitment@astrazeneca.com,  SwedenRecruitment@astrazeneca.com,  lakemedelsinformation@astrazeneca.com,  ann-leena.mikiver@astrazeneca.com,  anna.carbin-ahlund@astrazeneca.com,  dag.nilsson@astrazeneca.com,  neil.mccrae@astrazeneca.com,  sarah.lindgreen@astrazeneca.com,  abigail.baron@astrazeneca.com,  jonathan.hunt@astrazeneca.com,  karl.hard@astrazeneca.com,  matti.ojanen@astrazeneca.com,  susan.blewett@astrazeneca.com,  barry.furr@astrazeneca.com,  channeary.mcdowell@astrazeneca.com,  rich.fante@astrazeneca.com

 glenn.engelmann@astrazeneca.com,  jim.helm@astrazeneca.com,  kathy.monday@astrazeneca.com,  david.nicoli@astrazeneca.com,  linda.palczuk@astrazeneca.com,  lisa.schoenberg@astrazeneca.com,  david.snow@astrazeneca.com,  jayne.stanier@astrazeneca.com,  ed.seage@astrazeneca.com,  tiffany.burke@astrazeneca.com,  shannon.miller@astrazeneca.com,  tony.jewell@astrazeneca.com,  leah.geib@astrazeneca.com,  troy.benavidez@astrazeneca.com,  emily.denney@astrazeneca.com,  blair.hains@astrazeneca.com,  rachelle.benson@astrazeneca.com,  donna.lutz@astrazeneca.com,  corey.windett@astrazeneca.com,  laura.woodin@astrazeneca.com

 saga.johansson@astrazeneca.com,  sofie.feyaerts@astrazeneca.com,  ales.kminek@astrazeneca.com,  miroslava.petrousova@astrazeneca.com,  vaclav.kourim@astrazeneca.com,  lenka.mala@astrazeneca.com,  curtis.williams@astrazeneca.com,  ian.wilson@astrazeneca.com,  richard.caplan@astrazeneca.com,  anders.aberg@astrazeneca.com,  rutger.folmer@astrazeneca.com,  viktoria.anashkina@astrazeneca.com


 louis.schweitzer@astrazeneca.com,  ir@astrazeneca.com,  bewerbungen.at@astrazeneca.com,  martin.mackay@astrazeneca.com,  jane.henney@astrazeneca.com,  bruce.burlington@astrazeneca.com,  marcus.wallenberg@astrazeneca.com,  john.buchanan@astrazeneca.com,  simon.appleby@astrazeneca.com,  viv.gill@astrazeneca.com,  katie.jackson-turner@astrazeneca.com,  jpmorgan.adr@wellsfargo.com,  nancy.rothwell@astrazeneca.com,  rudy.markham@astrazeneca.com,  michele.hooper@astrazeneca.com,  john.varley@astrazeneca.com,  jean-philippe.courtois@astrazeneca.com,  shriti.vadera@astrazeneca.com

 luc.vranken@astrazeneca.com,  helmut.pauliny@astrazeneca.com,  irene.helk-schlaeger@astrazeneca.com,  martin.fuchs@astrazeneca.com,  martin.munte@astrazeneca.com,  rudi.dobber@astrazeneca.com,  peter.prokop@astrazeneca.com,  johannes.farkas@astrazeneca.com,  elmar.fleck@astrazeneca.com,  benoit.quittre@astrazeneca.com,  jeff.pott@astrazeneca.com

 CorporateAffairs.Portugal@astrazeneca.com,  patientsafety.portugal@astrazeneca.com,  infomed.pt@astrazeneca.com,  direccao.tecnica@astrazeneca.com,  apoio.cliente@astrazeneca.com,  ap.portugal@astrazeneca.com,  EBSAPPortugal@astrazeneca.com,  hrptaz@astrazeneca.com,  eduardo.recoder@astrazeneca.com,  miriam.moreno-manzanaro@astrazeneca.com,  esteban.medina@astrazeneca.com,  milan.lopasovsky@astrazeneca.com,  jean-pierre.valentin@astrazeneca.com

 paul.hudson@astrazeneca.com,  sonia.cal@astrazeneca.com,  guillermo.dejuan@astrazeneca.com,  luis.massa@astrazeneca.com,  ana.ponzoda@astrazeneca.com,  jesus.ponce@astrazeneca.com,  ines.margalet@astrazeneca.com,  federico.fuchs@astrazeneca.com,  federico.plaza@astrazeneca.com,  kasra.afsarinejad@astrazeneca.com,  olivier.guilbaud@astrazeneca.com,  frances.charlesworth@astrazeneca.com,  rosario.marazuela@astrazeneca.com,  jeremy.parker@astrazeneca.com,  russell.bialecki@astrazeneca.com,  tim.hammond@astrazeneca.com,  thomas.marks@astrazeneca.com

 esra.erkal-paler@astrazeneca.com,  nicklas.westerholm@astrazeneca.com,  anne-charlotte.knutsson@astrazeneca.com,  dave.laffan@astrazeneca.com,  colin.thomson@astrazeneca.com,  dave.laffan@astrazeneca.com,  dave.vosvenieks@astrazeneca.com,  mari-ann.wallander@astrazeneca.com,  saga.johansson@astrazeneca.com,  nicolaas.schipper@astrazeneca.com,  teresa.klinowska@astrazeneca.com,  georgina.speake@astrazeneca.com,  john.vincent@astrazeneca.com,  cath.trigwell@astrazeneca.com,  judith.anderton@astrazeneca.com,  sarah.beck@astrazeneca.com,  gayle.marshall@astrazeneca.com,  sara.davenport@astrazeneca.com,  rowena.callis@astrazeneca.com,  elizabeth.mills@astrazeneca.com,  paul.smith@astrazeneca.com,  robert.wilkinson@astrazeneca.com,  bernard.barlaam@astrazeneca.com,  julien.giovannini@astrazeneca.com

 raija.vakkila@astrazeneca.com,  steve.rees@astrazeneca.com,  maarit.hamalainen@astrazeneca.com,  gunnar.o.olsson@astrazeneca.com,  paul.ciaccio@astrazeneca.com,  adriane.spencer2@astrazeneca.com,  infomaster@astratech.com,  info.au@astratech.com,  info.at@astratech.com,  order.dental.at@astratech.com,  info.dk@astratech.com,  export.se@astratech.com,  info.fi@astratech.com,  info.fr@astratech.com,  info.de@astratech.com,  info.it@astratech.com,  info.jp@astratech.com,  info.nl@astratech.com,  info.no@astratech.com,  philippe.walker1@astrazeneca.com,  lilian.yengi@astrazeneca.com

 info.pl@astratech.com,  info.es@astratech.com,  info.se@astratech.com,  info.ch@astratech.com,  info.uk@astratech.com,  customerservice.us@astratech.com,  info.urology.us@astratech.com,  dona.corsen@astrazeneca.com,  jackson.gibbs@astrazeneca.com,  odete.correia@astrazeneca.com,  mark.a.smith@astrazeneca.com,  joanne.davis@astrazeneca.com,  mausumee.guha@astrazeneca.com,  annabelle.heier@astrazeneca.com,  sally.a.price@astrazeneca.com,  margareta.bielenstein@astrazeneca.com,  robert.caccese@astrazeneca.com,  dan.heathcote@astrazeneca.com,  thomas.simpson@astrazeneca.com,  thomas.simpson@boehringer-ingelheim.com,  david.stong@astrazeneca.com,  elmarie.bodes@astrazeneca.com

 mina.blair@astrazeneca.com,  jackson.gibbs@astrazeneca.com,  anna.ollerstam@astrazeneca.com,  amina.varga@astrazeneca.com,  maged.gobran@astrazeneca.com,  vance.warren@astrazeneca.com,  silke.klick@astrazeneca.com,  andrew.hughes@astrazeneca.com,  anne.berry@astrazeneca.com,  clyde.james@astrazeneca.com,  ken.mattes@astrazeneca.com,  peisan.lam@astrazeneca.com,  ken.fasman@astrazeneca.com,  suzette.schultz@astrazeneca.com,  charles.gillean@astrazeneca.com,  per.h.svensson@astrazeneca.com,  campbell.wilson@astrazeneca.com,  clive.armitage@astrazeneca.com,  hussain.mulla@astrazeneca.com

 ratan.bhat@astrazeneca.com,  yafeng.xue@astrazeneca.com,  stefan.berg@astrazeneca.com,  sven.hellberg@astrazeneca.com,  mats.ormoe@astrazeneca.com,  yvonne.nilsson@astrazeneca.com,  ann-cathrin.radesaeter@astrazeneca.com,  eva.jerning@astrazeneca.com,  per-olof.markgren@astrazeneca.com,  thomas.borgegard@astrazeneca.com,  susan.ashwell@astrazeneca.com,  sonya.zabludoff@astrazeneca.com,  probir.guha@astrazeneca.com,  orest.lastow@astrazeneca.com,  adrian.senderowicz@astrazeneca.com,  christian.dreger@astrazeneca.com

 neil.carragher@astrazeneca.com,  peter.caie@astrazeneca.com,  rebecca.walls@astrazeneca.com,  alexandra.ingleston-orme@astrazeneca.com,  sandeep.daya@astrazeneca.com,  tom.houslay@astrazeneca.com,  helen.c.brown@astrazeneca.com,  charles.gillean@astrazeneca.com,  martin.nylof@astrazeneca.com,  johan.malmstrom@astrazeneca.com,  henrik.lindberg@astrazeneca.com,  claes.lindberg@astrazeneca.com,  charlotte.bratt@astrazeneca.com,  bernstein9@aol.com

 elisabet.wieslander@astrazeneca.com,  eva-lena.delander@astrazeneca.com,  bengt.sarnstrand@astrazeneca.com,  jorge.burns@astrazeneca.com,  peter.mose-larsen@astrazeneca.com,  stephen.fey@astrazeneca.com,  gyorgy.marko-varga@astrazeneca.com,  per-henrik.zingmark@astrazeneca.com,  greg.sylvestre@astrazeneca.com,  joachim.grevel@astrazeneca.com,  marianne.ratcliffe@astrazeneca.com,  tomas.realiza@astrazeneca.com,  boudewijn.dejonge@astrazeneca.com,  mats.ogren@astrazeneca.com,  david.bergqvist@astrazeneca.com,  tim.french@astraZeneca.com

 christine.chresta@astrazeneca.com,  barry.davies@astrazeneca.com,  tom.harding@astrazeneca.com,  sabina.cosulich@astrazeneca.com,  susan.critchlow@astrazeneca.com,  john.vincent@astrazeneca.com,  rebecca.ellston@astrazeneca.com,  darren.jones@astrazeneca.com,  patrizia.sini@astrazeneca.com,  dominic.james@astrazeneca.com,  zoe.howard@astrazeneca.com,  phillippa.dudley@astrazeneca.com,  gareth.hughes@astrazeneca.com,  richard.jenkins@astrazeneca.com,  matt.jacobsen@astrazeneca.com,  graeme.smith@astrazeneca.com,  sylvie.guichard@astrazeneca.com,  martin.pass@astrazeneca.com,  julie.hayes@astrazeneca.com,  ann.doherty@astrazeneca.com,  deborah.adkins@astrazeneca.com,  karen.oldman@astrazeneca.com,  michael.odonovan@astrazeneca.com

 peter.bernstein@astrazeneca.com,  beverly.dickason@astrazeneca.com,  juliet.sellschop@astrazeneca.com,  terry.reed@astrazeneca.com,  kathleen.zemanek@astrazeneca.com,  cecelia.bagley@astratech.com,  kristin.samuelsson@astrazeneca.com,  kathryn.pickup@astrazeneca.com,
 john.swales@astrazeneca.com,  james.yates@astrazeneca.com,  christopher.smith@astrazeneca.com,  richard.gallagher@astrazeneca.com,  ian.wilson@astrazeneca.com,  charles.carr@astrazeneca.com